Search

  • HOME
  • Search
Original Article
733
Zoledronate Therapy in Osteogenesis Imperfecta: Perspectives in Indonesia Tertiary Hospital
Tri Wahyu Martanto, Aliefio Japamadisaw, Dian Nurhayati, Rob G. H. H. Nelissen
J Bone Metab. 2024;31(4):290-295.   Published online November 4, 2024
View: 532   Download: 30
651
Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Ae Jin Jeong, Song-Hee Lee, Sang-Kyu Ye, Chan Soo Shin
J Bone Metab. 2022;29(2):93-101.   Published online May 31, 2022
View: 4107   Download: 129  Citations: 7
608
Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year
Tarun Kadaru, Amal Shibli-Rahhal
J Bone Metab. 2021;28(1):51-58.   Published online February 28, 2021
View: 6354   Download: 202  Citations: 6
Could Prior Oral-bisphosphonate Administration Reduce the Acute Phase Reaction of Zoledronate?
서성화조환성천상호정혜미박일형*
J Bone Metab. 2011;18(1):49-54.
View: 1170   Download: 9
Predictors of Acute Phase Response after Intravenous Zoledronic Acid in Patients with Osteoporotic Fracture
Young-Kyun Lee Ji Hoon Baek Yong-Chan Ha* Kyung-Hoi Koo
J Bone Metab. 2010;17(2):103-107.
View: 1109   Download: 4

Journal of Bone
Metabolism

Print ISSN: 2287-6375
Online ISSN: 2287-7029



Editorial Office
#1001, Hyundai Kirim Officetel, 42 Seocho-daero 78-gil, Seocho-gu, Seoul 06626, Korea
Tel: +82-2-3473-2231    Fax: +82-70-4156-2230    E-mail: jbm@ksbmr.org                

Copyright © 2025 by The Korean Society for Bone and Mineral Research.

Developed in M2PI

Close layer
prev next